• Home
  • Industry
  • Innovation
  • Market
  • Materials
  • Products
  • Subscribe
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Lost your password?
Forgotten Password
Cancel
  • Home
  • Industry
  • Products
  • Materials
  • Innovation
  • Market
  • Sustainability
  • Regulatory
  • About Us
    • President’s Message
    • The Chemical Daily
  • Subscribe
    • Q & A
    • Subscribe Now
    • Manage my Subscription
    • Subscribe to our E-Mail Newsletter
  • 日本語
    • 化学工業日報
    • 広告掲載について

Kaneka Executive Officer Naoki Furukawa Details Efforts in Four Key Segments

Apr. 30, 2019

Filed Under: R&D Special Feature Tagged With: aviation, health care, Kaneko, materials development, Naoki Furukawa, nutrition, R&D, solar

The Chemical Daily recently conducted a round of interviews with the heads of R&D divisions of major Japanese chemical companies. For this installment, we talked with Naoki Furukawa, executive officer of Kaneka Corp. (TYO:4118).

Furukawa noted that Kaneka goes about development through a system of four segments that the company refers to as Solution Units. These are the Material, Quality of Life (QoL), Health Care and Nutrition Solution Units.

In the area of materials, Furukawa said that biodegradable polymers represent one high-priority theme for Kaneka. He noted that a market for these polymers has already formed in Europe, where plastics-related legislation continues to advance. And there is also the potential, he said, that needs for such materials will grow tremendously in other markets around the world, including those of the U.S. and Japan.

For other efforts in the segment, Furukawa said that Kaneka is making use of open innovation as it expands its materials operations. On the business side of things, this is seeing the company work with its customers on plastic manufacturing technologies, the development of new applications and even business operations, he explained.

Kaneka’s Material Solution Unit is also focused on composite materials, Furukawa said. And this includes the aviation sector, he noted, where Kaneka has acquired companies that are engaged in raw materials and compound resin technologies for aircraft parts. Furukawa said that this has given the company a lineup of materials that to some extent provide heat resistance to a range of different temperatures – examples in this lineup being epoxy, polyimide and benzoxazine resins.

Moving then to the topic of Kaneka’s QoL Solution Unit, Furukawa said that one core of operations here is solar cells, where the company is aiming for the world’s highest conversion efficiency. By working on research alongside Belgian-based IMEC, Kaneka hopes to become even better at presenting solutions to energy-related social issues, he said.

In its Health Care Solution Unit, Furukawa said, Kaneka is aiming to get new developments into society in the near future. This includes the area of regenerative medicine and cell therapy, he noted, where the company is working to facilitate the supply of cells to companies, universities and research institutions looking to apply treatment.

Furukawa then noted that Kaneka established a new strategic unit last year for the development of pharmaceuticals and other medical treatments. The unit serves to advance Kaneka’s development of new businesses in the medical sector, he said – including businesses revolving around new treatments.

Kaneka’s Nutrition Solution Unit is similarly looking to find practical uses for its efforts in the near future. Here, Furukawa said, the company is aiming to support food production, and has conducted joint development to this end alongside Japan’s National Agriculture and Food Research Organization (NARO). This has seen the company develop technologies for genetically modified crops by combining genome editing technology with gene transfer technology.

Related Articles:

Kaneka Eyes Major M&A Deals in Health Care SectorKaneka Eyes Major M&A Deals in Health Care Sector
Kaneka, Seven & I Holdings to Jointly Develop Biodegradable Plastic ProductsKaneka, Seven & I Holdings to Jointly Develop…
DIC Executive Officer Kiyotaka Kawashima Discusses Priority Areas for DevelopmentDIC Executive Officer Kiyotaka Kawashima Discusses…
Nippon Shokubai Senior Managing Executive Officer Yojiro Takahashi Talks Development EffortsNippon Shokubai Senior Managing Executive Officer…
Kaneka Fiberizes PHBH, Targets New Uses for Tackling Ocean Plastic WasteKaneka Fiberizes PHBH, Targets New Uses for Tackling…
Tokuyama Executive Officer Fumiaki Iwasaki Provides Insight into R&D StrategyTokuyama Executive Officer Fumiaki Iwasaki Provides…
Previous Post: « Daicel Director Hisao Nishimura Talks Efforts in Five New Business Units
Next Post: Maruzen Petrochemical Managing Director Yutaka Kawabata Talks Development Plans »

Primary Sidebar

Latest Articles

Waseda, Eneos Develop Catalyst for Recycling CO2 to CO

Jan. 15, 2021

Interview: Sumitomo Chemical President Keiichi Iwata Talks Investments, Strategy

Jan. 15, 2021

Tokyo Tech Works on New Form of Photodynamic Cancer Treatment

Jan. 15, 2021

Asahi Kasei Takes Aim at Automotive Market for Environmentally Friendly Curing Agents

Jan. 14, 2021

Interview: Asahi Kasei President Hideki Kobori Talks Industry Trends, Strategy

Jan. 14, 2021

Most Popular

  • Mitsubishi Chemical to Boost Production of EVOH for Use in Food Packaging
  • Interview: Mitsubishi Chemical CEO Masayuki Waga Discusses Company Path Amid Increasingly Unclear External Factors
  • Coronavirus Report: Part 1 – Japanese Chemical Companies in China See Potential for Negative Impact on Business
  • Coronavirus Report: Part 4 – Japanese Chemical Firms Anxious Over Resuming Operations
  • Coronavirus Report: Part 3 – Companies Concerned Over Potential Effects on Southeast Asia

Tags

5G asahi kasei Automotive automotive materials batteries carbon fiber china coronavirus electric vehicles environment ethylene health care industry trends interview investments LiB M&A market conditions market prices medical METI Mitsubishi Chemical Mitsubishi Chemical Holdings Mitsui Chemicals new materials petrochemical pharmaceutical polyethylene polypropylene production production increase R&D recycling Sekisui Chemical semiconductors Showa Denko strategy Sumitomo Chemical supply and demand Teijin thailand Toray tosoh U.S. ube industries

Footer

Log In


Lost your password?
Forgotten Password
Cancel

Links

Home
About
広告掲載について
Terms of Use
Privacy Policy
Legal Notice
Notation on the Specified Commercial Transaction Act
Contact us

© 2016–2021 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.

japan-industry-news-network_logo

Copyright © 2021 · Chemical Daily v2 on Genesis Framework · WordPress · Log in

Free Read: R&D Special Feature

Close window

{"cookieName":"wBounce","isAggressive":false,"isSitewide":true,"hesitation":"","openAnimation":"fadeIn","exitAnimation":false,"timer":"","sensitivity":"","cookieExpire":"3","cookieDomain":"","autoFire":"","isAnalyticsEnabled":false}